Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1990 4
1991 1
1992 2
1993 5
1994 1
1995 3
1996 1
1999 2
2000 1
2001 1
2002 3
2003 1
2004 1
2005 1
2006 4
2007 3
2008 5
2009 5
2010 4
2011 4
2012 6
2013 6
2014 10
2015 6
2016 4
2017 6
2018 10
2019 8
2020 5
2021 7
2022 13
2023 13
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.
Hirani N, MacKinnon AC, Nicol L, Ford P, Schambye H, Pedersen A, Nilsson UJ, Leffler H, Sethi T, Tantawi S, Gravelle L, Slack RJ, Mills R, Karmakar U, Humphries D, Zetterberg F, Keeling L, Paul L, Molyneaux PL, Li F, Funston W, Forrest IA, Simpson AJ, Gibbons MA, Maher TM. Hirani N, et al. Among authors: mackinnon ac. Eur Respir J. 2021 May 27;57(5):2002559. doi: 10.1183/13993003.02559-2020. Print 2021 May. Eur Respir J. 2021. PMID: 33214209 Free PMC article. Clinical Trial.
Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3.
Mackinnon AC, Gibbons MA, Farnworth SL, Leffler H, Nilsson UJ, Delaine T, Simpson AJ, Forbes SJ, Hirani N, Gauldie J, Sethi T. Mackinnon AC, et al. Am J Respir Crit Care Med. 2012 Mar 1;185(5):537-46. doi: 10.1164/rccm.201106-0965OC. Epub 2011 Nov 17. Am J Respir Crit Care Med. 2012. PMID: 22095546 Free PMC article.
Galectin-3: therapeutic targeting in liver disease.
Mackinnon AC, Tonev D, Jacoby B, Pinzani M, Slack RJ. Mackinnon AC, et al. Expert Opin Ther Targets. 2023 Jul-Dec;27(9):779-791. doi: 10.1080/14728222.2023.2258280. Epub 2023 Sep 15. Expert Opin Ther Targets. 2023. PMID: 37705214 Review.
Utility of Single-Gene Testing in Cancer Specimens.
Hanbazazh M, Morlote D, Mackinnon AC, Harada S. Hanbazazh M, et al. Among authors: mackinnon ac. Clin Lab Med. 2022 Sep;42(3):385-394. doi: 10.1016/j.cll.2022.05.001. Epub 2022 Aug 22. Clin Lab Med. 2022. PMID: 36150818 Review.
Tracking in anatomic pathology.
Pantanowitz L, Mackinnon AC Jr, Sinard JH. Pantanowitz L, et al. Among authors: mackinnon ac jr. Arch Pathol Lab Med. 2013 Dec;137(12):1798-810. doi: 10.5858/arpa.2013-0125-SA. Epub 2013 May 1. Arch Pathol Lab Med. 2013. PMID: 23634908 Free article. Review.
The Interpretation of Sequence Variants in Myeloid Neoplasms.
Hanbazazh M, Harada S, Reddy V, Mackinnon AC, Harbi D, Morlote D. Hanbazazh M, et al. Among authors: mackinnon ac. Am J Clin Pathol. 2021 Oct 13;156(5):728-748. doi: 10.1093/ajcp/aqab039. Am J Clin Pathol. 2021. PMID: 34155503 Review.
Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation.
Humphries DC, Mills R, Boz C, McHugh BJ, Hirani N, Rossi AG, Pedersen A, Schambye HT, Slack RJ, Leffler H, Nilsson UJ, Wang W, Sethi T, Mackinnon AC. Humphries DC, et al. Among authors: mackinnon ac. Front Pharmacol. 2022 Aug 8;13:949264. doi: 10.3389/fphar.2022.949264. eCollection 2022. Front Pharmacol. 2022. PMID: 36003515 Free PMC article.
136 results